| Sign In to gain access to subscriptions and/or personal tools. |
Lupus around the WorldOutcome of a national Israeli cohort of pediatric systemic lupus erythematosusYosef Uziel, Pediatric Rheumatology, Department of Pediatrics, Meir Medical Center, Kfar-Saba, 44281, Israel.; uziely{at}zahav.net.il; Meir Medical Center, Tel Aviv University Kfar-Saba, Isreal
Meir Medical Center, Tel Aviv University Kfar-Saba, Isreal
Schneider Medical Center, Tel Aviv University Petah-Tikva, Isreal
Sheba Medical Center, Tel Aviv University Tel-Hashomer, Isreal
Rambam Hospital, Technion Medical School Haifa, Isreal
Kaplan Hospital, Hebrew University Rehovot, Isreal
Hadassah Medical Center, Hebrew University Jerusalem, Isreal
Sheba Medical Center, Tel Aviv University Tel-Hashomer, Isreal
Asaf-Harofeh Hospital, Tel Aviv University Zerifin, Isreal
Soroka Medical Center, Hanegev University Beer-Sheva, Isreal
Schneider Medical Center, Tel Aviv University Petah-Tikva, Isreal
Shaarei-Zedek Medical Center, Hanegev University Jerusalem, Isreal
Safed Cleveland Clinic Foundation, OH, USA
Hadassah Medical Center, Hebrew University Jerusalem, Isreal
Department of Rheumatic Diseases, Cleveland Clinic Foundation, OH, USA The aim of this study was to describe the clinical manifestations and outcomes of a national cohort of childhood systemic lupus erythematosus (cSLE). All cases of cSLE registered in the Israeli national registry of children with rheumatic diseases between 19872003 were examined for disease activity and damage by the SLE disease activity index (SLEDAI) and SLE collaborating clinics/American College of Rheumatology (SLICC/ACR) damage index. Demographic, clinical, laboratory and treatment factors were analysed for their effect on the outcome. One-hundred and two patients were identified, 81% females, with a mean age at diagnosis of 13.3 ± 2.6 years. The mean SLEDAI score was 17.2 ± 9.0 (range 260). Fifty four patients were followed for at least five years. The mean SLEDAI decreased to 7.6 ± 6.3 (029) and the mean SLICC/ACR damage index was 0.7 ± 1.6 (08). Five patients developed chronic renal failure. No patients died. No factors were found to be significantly associated with the outcome except the initial SLEDAI score. The five-year outcome of our national cSLE cohort was good; with relatively low activity and minimal damage in most patients. The initial SLEDAI predicted the development of late damage.
Key Words: outcome pediatrics SLEDAI systemic lupus erythematosus
Lupus, Vol. 16, No. 2,
142-146 (2007) |
|||